12.32
price up icon0.00%   0.00
after-market Handel nachbörslich: 12.28 -0.04 -0.32%
loading

Finanzdaten der Ocular Therapeutix Inc-Aktie (OCUL)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-09-30 2024-06-30 2024-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
25.81%
13.46
10.70 15.43 16.44 14.77
Cost Of Revenue
54.04%
1.944
1.262 1.561 1.509 1.326
Gross Profit
22.03%
11.52
9.436 13.86 14.93 13.45
Operating Expenses
7.91%
79.16
73.35 59.86 58.52 45.06
Benefits Costs and Expenses
8.49%
81.10
74.75 61.42 60.03 79.62
Costs And Expenses
8.69%
81.10
74.61 61.42 60.03 46.39
Operating Income/Loss
5.83%
-67.64
-63.92 -46.00 -43.59 -31.62
Nonoperating Income/Loss
27.21%
-0.173
-0.136 9.505 -0.187 -33.23
Income/Loss From Continuing Operations Before Tax
5.60%
-67.64
-64.05 -46.00 -43.78 -64.85
Income/Loss From Continuing Operations After Tax
5.87%
-67.81
-64.05 -36.49 -43.78 -64.85
Net Income/Loss
5.87%
-67.81
-64.05 -36.49 -43.78 -64.85
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
1.89%
172.59
169.40 166.99 165.82 132.02
Diluted Average Shares
1.89%
172.59
169.40 166.99 165.82 132.02
Basic Earnings Per Share
2.63%
-0.39
-0.38 -0.22 -0.26 -0.49
Diluted Earnings Per Share
2.63%
-0.39
-0.38 -0.22 -0.26 -0.49
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$24.78
price up icon 0.98%
$84.84
price up icon 1.00%
$24.80
price down icon 8.06%
$103.01
price down icon 1.70%
$134.53
price up icon 1.79%
biotechnology ONC
$300.14
price down icon 2.84%
Kapitalisierung:     |  Volumen (24h):